Hans-Georg Opitz

Title: The Innovative Mind of Hans-Georg Opitz: A Pioneer in Peptide Technology

Introduction: Hans-Georg Opitz, an accomplished inventor based in Weinheim, Germany, has made significant contributions to the field of peptide technology. With five registered patents to his name, Opitz continues to push the boundaries of innovation, focusing on methods that enhance our understanding of organism health through peptide measurement.

Latest Patents: Among Hans-Georg Opitz's latest patents is a groundbreaking process for determining the status of an organism by peptide measurement. This method involves detecting the condition of an organism through the analysis of peptides from samples, which include both high- and low-molecular weight peptides. This innovative approach serves as an important indicator of the organism's health.

Another notable invention is related to cadherin-derived growth factor (CDGF). This peptide corresponds to a partial sequence of a pre-pro-cadherin, which includes significant domains such as the signal sequence, pro sequence, cadherin repeats, transmembrane region, and intracellular domain. The invention is characterized by the absence of at least one domain from the pre-pro-cadherin, resulting in a peptide that exhibits cell-proliferative, cell-protective, and cell-differential properties. This research holds immense potential for advancements in medical science.

Career Highlights: Throughout his career, Hans-Georg Opitz has demonstrated a strong commitment to innovation and research. His work is recognized in both academic and commercial fields, reflecting his versatility and dedication to advancing technology. His background includes positions in significant companies, particularly Biovision AG, where his research focused on developing practical applications for his inventions.

Collaborations: Hans-Georg Opitz has collaborated with several esteemed professionals in his field, notably Wolf-Georg Forssmann and Dieter Herrmann. These collaborations have not only enhanced his research capabilities but have also contributed to groundbreaking advancements in peptide studies.

Conclusion: Hans-Georg Opitz stands out as a prominent inventor whose work in peptide technology has the potential to revolutionize our understanding of health and disease. With five patents and a commitment to innovation, Opitz's contributions are paving the way for future breakthroughs in the life sciences. His collaborations and dedication to research exemplify the spirit of invention that drives progress in this essential area of study.